This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2013-2016.
Location History:
- Uttar Pradesh, IN (2015)
- Lucknow, IN (2013 - 2016)
Company Filing History:
Years Active: 2013-2016
Title: Bholanath Paul: Innovator in Asthma Treatment
Introduction
Bholanath Paul is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medical research, particularly in the treatment of bronchial asthma. With a total of 3 patents to his name, his work focuses on innovative compounds that target specific pathways involved in asthma.
Latest Patents
One of his latest patents is titled "Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma." This invention relates to compounds designed to inhibit the IL-4 or IL-5 pathways, which are crucial in the development of bronchial asthma. The method involves administering these compounds through various routes, including oral, intranasal, or inhalation, to effectively reduce inflammation in affected mammals.
Another significant patent is "Triazine-aryl-bis-indoles and process for preparation thereof." This invention introduces a novel heterocyclic compound that is useful for asthma treatment. The patent outlines the process for preparing these compounds and demonstrates the pathway through which they inhibit asthma symptoms.
Career Highlights
Bholanath Paul is associated with the Council of Scientific & Industrial Research, where he conducts his research and development activities. His work has been instrumental in advancing the understanding and treatment of asthma, showcasing his commitment to improving patient outcomes.
Collaborations
He has collaborated with notable colleagues such as Santu Bandyopadhyay and Siddhartha Roy. Their combined expertise has contributed to the successful development of innovative solutions in the field of respiratory health.
Conclusion
Bholanath Paul's contributions to asthma treatment through his innovative patents highlight his role as a leading inventor in the medical research community. His work continues to pave the way for new therapeutic approaches to managing bronchial asthma.